Literature DB >> 2660071

The c-ets-1 protein is chromatin associated and binds to DNA in vitro.

P Pognonec1, K E Boulukos, J Ghysdael.   

Abstract

The c-ets-1 proto-oncogene is expressed at high levels in proliferating lymphoid cells. We show here that the chicken and murine c-ets-1 proteins are predominantly localized in the cell nucleus. Over 90% of the c-ets-1 protein can be released from isolated thymocyte nuclei by treatment with low salt buffer. Release from nuclei is also observed after treatment with micrococcal nuclease, but not with RNaseA, in conditions where digestion of only a minor fraction of chromatin occurs. c-ets-1 proteins exhibit DNA binding activity, suggesting that the association to chromatin is mediated at least in part by their association to DNA. We previously showed that mitogenic stimulation of thymocytes is accompanied by the rapid calcium-dependent phosphorylation of c-ets-1 proteins. We demonstrate here that these phosphorylation events abolish the ability of c-ets-1 proteins to bind to DNA in vitro and reduce their affinity for chromatin, lending further support to the importance of these modifications in the regulation of c-ets-1 protein function.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2660071

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  24 in total

1.  Sp100 interacts with ETS-1 and stimulates its transcriptional activity.

Authors:  Christine Wasylyk; Sophie E Schlumberger; Paola Criqui-Filipe; Bohdan Wasylyk
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

2.  c-ets1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans.

Authors:  N Wernert; M B Raes; P Lassalle; M P Dehouck; B Gosselin; B Vandenbunder; D Stehelin
Journal:  Am J Pathol       Date:  1992-01       Impact factor: 4.307

3.  A positive regulator of the ribosomal protein gene, beta factor, belongs to the ETS oncoprotein family.

Authors:  T Yoganathan; N K Bhat; B H Sells
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

4.  Recombinant 43-kDa USF binds to DNA and activates transcription in a manner indistinguishable from that of natural 43/44-kDa USF.

Authors:  P Pognonec; R G Roeder
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

5.  Sequence-specific interaction of the Ets1 protein with the long terminal repeat of the human T-lymphotropic virus type I.

Authors:  S D Gitlin; R Bosselut; A Gégonne; J Ghysdael; J N Brady
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

6.  Molecular cloning of the human UMP synthase gene and characterization of point mutations in two hereditary orotic aciduria families.

Authors:  M Suchi; H Mizuno; Y Kawai; T Tsuboi; S Sumi; K Okajima; M E Hodgson; H Ogawa; Y Wada
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

7.  Reciprocal expression of human ETS1 and ETS2 genes during T-cell activation: regulatory role for the protooncogene ETS1.

Authors:  N K Bhat; C B Thompson; T Lindsten; C H June; S Fujiwara; S Koizumi; R J Fisher; T S Papas
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

8.  Definition of an Ets1 protein domain required for nuclear localization in cells and DNA-binding activity in vitro.

Authors:  K E Boulukos; P Pognonec; B Rabault; A Begue; J Ghysdael
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

9.  DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma.

Authors:  R A Bailly; R Bosselut; J Zucman; F Cormier; O Delattre; M Roussel; G Thomas; J Ghysdael
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

Review 10.  Review of Ets1 structure, function, and roles in immunity.

Authors:  Lee Ann Garrett-Sinha
Journal:  Cell Mol Life Sci       Date:  2013-01-05       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.